Clinical Trials Browser

Phase 2 × Adrenal Cortex Neoplasms × Nivolumab × Clear all

NCT02720484 2019-05-01

Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer

Phase 2 Terminated

10 enrolled 11 charts

Adrenal Cortex Neoplasms